Loading...
XSHG
600833
Market cap435mUSD
Dec 05, Last price  
13.81CNY
1D
-0.14%
1Q
-2.26%
Jan 2017
-32.80%
Name

Shanghai No.1 Pharmacy Co Ltd

Chart & Performance

D1W1MN
XSHG:600833 chart
P/E
18.89
P/S
1.61
EPS
0.73
Div Yield, %
0.91%
Shrs. gr., 5y
0.03%
Rev. gr., 5y
9.03%
Revenues
1.92b
+5.26%
601,617,263602,934,141909,996,776964,530,1701,036,970,3271,147,475,7261,268,327,1221,357,670,3591,348,394,8081,414,745,4201,490,959,7551,519,029,3971,556,146,2051,176,665,7621,243,169,4881,586,903,7251,398,284,9992,655,908,5241,819,516,1651,915,159,000
Net income
163m
+82.65%
14,205,41312,969,53520,061,41320,014,91040,003,63730,324,41736,748,65036,434,33834,266,80037,024,83941,168,49446,034,16243,476,77147,186,33253,089,38268,540,92249,419,058143,556,29389,275,234163,061,000
CFO
49m
-16.18%
14,215,35682,998,24341,350,17120,715,40527,061,26439,915,98824,666,24456,248,1286,519,98119,198,82848,821,43336,371,167120,074,11242,793,435104,601,58184,241,40136,559,506132,310,96658,492,29149,027,000
Dividend
Jun 21, 20240.125 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shanghai No.1 Pharmacy Co., Ltd. engages in the retail and wholesale of pharmaceutical products. The company offers products in the categories of Chinese and Western medicines, nutrition and health products, medical equipment, Chinese herbal medicines, etc. In addition, it provides consulting and guidance on safe medication, rational medication, and chronic disease medication. Shanghai No. 1 Pharmacy Co., Ltd. is based in Shanghai, China.
IPO date
Feb 24, 1994
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT